Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Publisher Home
About
About the Journal
Submissions
Privacy Statement
Editorial Team
Issues
Current
Archives
Browse by Author
Journal Policies
Focus & Scope
Author Guidelines
Reviewers Guidelines
Editor's Guidelines
Publication Ethics
Plagiarism Policy
Peer Review Policy
Indexing
Contact Us
Search
Search
Search
Search
Home
/
Archives
/
Vol. 3 No. 3 (2024): Volume 3, Issue 3, 2024
Vol. 3 No. 3 (2024): Volume 3, Issue 3, 2024
DOI:
https://doi.org/10.26452/ijebr.v3i3
Published:
2024-07-08
Original Article
A new method of development and validation of Methanesulfonic acid ester (Methyl, Ethyl) impurity content in dabigatran etexilate mesylate by GC MS
Mohammed Ameen Basha Shaik, Shahidha Bee S
35-39
44
PDF
21
Prosopagnosia: face blindness and its relationship to neurological disorders
Gautham Chakra R, Kasichetana Sri K, Aparna G, Reddy Sravani K, Mahesh Kumar Reddy V, Fayaz S, Sravan Kushal M
12-28
168
PDF
44
DESCRIPTION OF DIABETES, RISK FACTORS, ADVANCEMENTS IN DIABETES TREATMENT, AND THE EFFECT OF DIET ON QUALITY OF LIFE
Dr. R Gautham chakra, Sk. Suhana, J. Naveen Kumar, V. Krishna Devi, G. Ulitappa, B. Hasini, K. Mahesh, A. Pradeep, S. Ashraf Ali
40-50
54
PDF
23
Review Article
Recent approaches of regulatory perspectives for the registration of drugs in southern states in India
Supriya Rathapani, Bharathi J, Sarah Sujitha Y
29-34
40
PDF
21
Present challenges and surveillance of artificial intelligence in neuro-oncology
Gautham Chakra R, Kavyanjali K, Sree D, Shaima SK, Govardhan B
1-11
87
PDF
36
Invitation for Submission
Keywords
